US pharmaceutical giant Pfizer could make a hostile bid for AstraZeneca as early as today.
Its £63 billion takeover offer was rejected after the UK company said it "substantially" undervalued the business.
That has forced Pfizer to consider its next move, with industry experts believing a hostile bid - which would aim to bypass the AstraZeneca management and target shareholders directly - could come soon.
Last week, Pfizer insisted it was committed to building a research and development hub in Cambridge which was planned by AstraZeneca.
The £300m base at the Cambridge Biomedial Campus would house about 2,000 researchers.
But a hostile bid would trigger increased calls for the offer to be referred to the competition authorities and would also heighten union fears over jobs if the takeover was successful.
More top news
A man is considering legal action against one of the region's major hospitals after his wife died following a routine operation.
Norwich City manager Alex Neil has urged his players to maintain their focus for tonight's crucial Championship clash with struggling Wigan.
A cancer patient who had a potentially life-saving operation postponed says he felt like doctors were "signing his death warrant."